论文部分内容阅读
十五期间深圳生物医药产业已形成良好的产业基础。2003年产值位居全国大中城市第3位。2004年产值170.1亿元,其中药品(含部分保健品)129亿元,较上年增长14%,医疗器械产品41亿元,较上年增长54%。一批跨国生物企业在深圳建有生产基地,如赛诺菲安万特、西门子、津村药业、奥林巴斯
During the 15th period, Shenzhen biomedicine industry has formed a good industrial foundation. 2003 output value ranks the country in the third place. The output value of 2004 was 17.01 billion yuan, of which, medicines (including some health products) were 12.9 billion yuan, an increase of 14% over the previous year and medical device products were 4.1 billion yuan, an increase of 54% over the previous year. A group of multinational biological enterprises have established production bases in Shenzhen, such as Sanofi-Aventis, Siemens, Tsumura Pharmaceutical, Olympus